TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs2535323
log Bayes Factor = 61.2993
Chromosome 6   position 30,718,180  (GRCh37) Explore rs2535323 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E03.9 Hypothyroidism, unspecified
0.000 0.000 1.000
E10.9 Without complications
0.000 0.000 1.000
K90.0 Coeliac disease
0.000 0.000 1.000
L40.9 Psoriasis, unspecified
1.000 0.000 0.000
L40.5 Arthropathic psoriasis
1.000 0.000 0.000
E10 Insulin-dependent diabetes mellitus
0.000 0.000 1.000
E00-E07 Disorders of thyroid gland
0.000 0.000 1.000
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.000 1.000
L40 Psoriasis
1.000 0.000 0.000
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.000 1.000
E05.9 Thyrotoxicosis, unspecified
0.000 0.000 1.000
E03 Other hypothyroidism
0.000 0.000 1.000
E10-E14 Diabetes mellitus
0.000 0.000 1.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.997 0.003 0.000
E10.3 With ophthalmic complications
0.000 0.003 0.997
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.005 0.995
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.995 0.005 0.000
E16 Other disorders of pancreatic internal secretion
0.000 0.009 0.991
E16.2 Hypoglycaemia, unspecified
0.000 0.011 0.989
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.011 0.989
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.989 0.011 0.000
E50-E64 Other nutritional deficiencies
0.000 0.017 0.983
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.980 0.020 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.971 0.029 0.000
E10.4 With neurological complications
0.000 0.038 0.962
E10.5 With peripheral circulatory complications
0.000 0.040 0.960
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.958 0.042 0.000
T43.2 Other and unspecified antidepressants
0.944 0.056 0.000
E10.1 With ketoacidosis
0.000 0.059 0.941
T43.0 Tricyclic and tetracyclic antidepressants
0.940 0.060 0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.939 0.061 0.000
E53 Deficiency of other B group vitamins
0.000 0.073 0.927
E55 Vitamin D deficiency
0.000 0.075 0.925
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.924 0.076 0.000
L40.0 Psoriasis vulgaris
0.917 0.083 0.000
T39.1 4-Aminophenol derivatives
0.911 0.089 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.900 0.100 0.000
E53.8 Deficiency of other specified B group vitamins
0.000 0.113 0.887
E55.9 Vitamin D deficiency, unspecified
0.000 0.118 0.882
T50.9 Other and unspecified drugs, medicaments and biological substances
0.880 0.120 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.870 0.130 0.000
E04 Other non-toxic goitre
0.000 0.134 0.866
L40.1 Generalised pustular psoriasis
0.864 0.136 0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.856 0.144 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.853 0.147 0.000
E04.9 Non-toxic goitre, unspecified
0.000 0.155 0.845
E06 Thyroiditis
0.000 0.161 0.839
T39.0 Salicylates
0.827 0.173 0.000
T42.4 Benzodiazepines
0.816 0.184 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.815 0.185 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.813 0.187 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.805 0.195 0.000
E03.8 Other specified hypothyroidism
0.000 0.198 0.802
E10.0 With coma
0.000 0.209 0.791
E10.6 With other specified complications
0.000 0.209 0.791
E10.8 With unspecified complications
0.000 0.213 0.787
L40.8 Other psoriasis
0.786 0.214 0.000
E10.2 With renal complications
0.000 0.231 0.769
T36 Poisoning by systemic antibiotics
0.758 0.242 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.755 0.245 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.742 0.258 0.000
E06.3 Autoimmune thyroiditis
0.000 0.265 0.735
E05.8 Other thyrotoxicosis
0.000 0.273 0.727
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.276 0.724
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.718 0.282 0.000
E05.5 Thyroid crisis or storm
0.000 0.283 0.717
E05.4 Thyrotoxicosis factitia
0.000 0.283 0.717
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.283 0.717
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.283 0.717
E10.7 With multiple complications
0.000 0.283 0.717
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.283 0.717
E00 Congenital iodine-deficiency syndrome
0.000 0.283 0.717
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.283 0.717
L40.4 Guttate psoriasis
0.717 0.283 0.000
L40.3 Pustulosis palmaris et plantaris
0.717 0.283 0.000
L40.2 Acrodermatitis continua
0.717 0.283 0.000
E03.5 Myxoedema coma
0.000 0.283 0.717
E03.4 Atrophy of thyroid (acquired)
0.000 0.283 0.717
E03.3 Postinfectious hypothyroidism
0.000 0.283 0.717
E03.0 Congenital hypothyroidism with diffuse goitre
0.000 0.283 0.717
E12 Malnutrition-related diabetes mellitus
0.000 0.283 0.717
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.715 0.285 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.715 0.285 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.715 0.285 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.715 0.285 0.000
E15 Nondiabetic hypoglycaemic coma
0.000 0.287 0.713
T43.9 Psychotropic drug, unspecified
0.713 0.287 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.713 0.287 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.713 0.287 0.000
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.289 0.711
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.289 0.711
E16.4 Abnormal secretion of gastrin
0.000 0.289 0.711
E16.3 Increased secretion of glucagon
0.000 0.289 0.711
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.709 0.291 0.000
T42.5 Mixed antiepileptics, not elsewhere classified
0.709 0.291 0.000
T42.3 Barbiturates
0.709 0.291 0.000
T42.2 Succinimides and oxazolidinediones
0.709 0.291 0.000
T42.0 Hydantoin derivatives
0.709 0.291 0.000
E61 Deficiency of other nutrient elements
0.000 0.293 0.707
T50.8 Diagnostic agents
0.707 0.293 0.000
E64 Sequelae of malnutrition and other nutritional deficiencies
0.000 0.295 0.705
E63 Other nutritional deficiencies
0.000 0.295 0.705
E56 Other vitamin deficiencies
0.000 0.295 0.705
E51 Thiamine deficiency
0.000 0.295 0.705
E50 Vitamin A deficiency
0.000 0.295 0.705
E60 Dietary zinc deficiency
0.000 0.295 0.705
E59 Dietary selenium deficiency
0.000 0.295 0.705
E58 Dietary calcium deficiency
0.000 0.295 0.705
E54 Ascorbic acid deficiency
0.000 0.295 0.705
E52 Niacin deficiency [pellagra]
0.000 0.295 0.705
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.696 0.304 0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.696 0.304 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.696 0.304 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.696 0.304 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.696 0.304 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.696 0.304 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.696 0.304 0.000
T44.0 Anticholinesterase agents
0.696 0.304 0.000
T43.6 Psychostimulants with abuse potential
0.691 0.308 0.000
T50.7 Analeptics and opioid receptor antagonists
0.687 0.313 0.000
T50.5 Appetite depressants
0.687 0.313 0.000
T50.4 Drugs affecting uric acid metabolism
0.687 0.313 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.687 0.313 0.000
T50.1 Loop [high-ceiling] diuretics
0.687 0.313 0.000
T50.0 Mineralocorticoids and their antagonists
0.687 0.313 0.000
T43.5 Other and unspecified antipsychotics and neuroleptics
0.684 0.316 0.000
E13 Other specified diabetes mellitus
0.000 0.317 0.683
E16.1 Other hypoglycaemia
0.000 0.326 0.674
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.673 0.327 0.000
T39.4 Antirheumatics, not elsewhere classified
0.673 0.327 0.000
T39.2 Pyrazolone derivatives
0.673 0.327 0.000
E53.9 Vitamin B deficiency, unspecified
0.000 0.335 0.665
E53.1 Pyridoxine deficiency
0.000 0.335 0.665
E53.0 Riboflavin deficiency
0.000 0.335 0.665
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.335 0.665
E55.0 Rickets, active
0.000 0.337 0.663
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.657 0.343 0.000
T47.0 Histamine H(2)-receptor antagonists
0.655 0.345 0.000
E03.1 Congenital hypothyroidism without goitre
0.000 0.351 0.649
T46.1 Calcium-channel blockers
0.648 0.352 0.000
E07 Other disorders of thyroid
0.000 0.356 0.644
T46.5 Other antihypertensive drugs, not elsewhere classified
0.641 0.359 0.000
T38.1 Thyroid hormones and substitutes
0.637 0.363 0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.623 0.376 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.623 0.376 0.000
T46.7 Peripheral vasodilators
0.623 0.376 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.623 0.376 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.623 0.376 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.623 0.376 0.000
T42.1 Iminostilbenes
0.622 0.378 0.000
E04.8 Other specified non-toxic goitre
0.000 0.379 0.621
T47.1 Other antacids and anti-gastric-secretion drugs
0.619 0.381 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.619 0.381 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.615 0.385 0.000
K90 Intestinal malabsorption
0.000 0.398 0.602
E06.5 Other chronic thyroiditis
0.000 0.399 0.601
E06.4 Drug-induced thyroiditis
0.000 0.399 0.601
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.000 0.399 0.601
E06.1 Subacute thyroiditis
0.000 0.399 0.601
E06.0 Acute thyroiditis
0.000 0.399 0.601
T36.0 Penicillins
0.587 0.413 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.583 0.417 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.583 0.417 0.000
T47.7 Emetics
0.583 0.417 0.000
T47.6 Antidiarrhoeal drugs
0.583 0.417 0.000
T47.5 Digestants
0.583 0.417 0.000
T47.4 Other laxatives
0.583 0.417 0.000
T47.3 Saline and osmotic laxatives
0.583 0.417 0.000
T47.2 Stimulant laxatives
0.583 0.417 0.000
T38.9 Other and unspecified hormone antagonists
0.577 0.422 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.577 0.422 0.000
T38.7 Androgens and anabolic congeners
0.577 0.422 0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.577 0.422 0.000
T38.5 Other oestrogens and progestogens
0.577 0.422 0.000
T38.4 Oral contraceptives
0.577 0.422 0.000
T38.2 Antithyroid drugs
0.577 0.422 0.000
T38.0 Glucocorticoids and synthetic analogues
0.577 0.422 0.000
E06.9 Thyroiditis, unspecified
0.000 0.427 0.573
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.000 0.430 0.569
E04.2 Non-toxic multinodular goitre
0.000 0.441 0.559
E40-E46 Malnutrition
0.000 0.450 0.549
T36.9 Systemic antibiotic, unspecified
0.544 0.456 0.000
T36.8 Other systemic antibiotics
0.544 0.456 0.000
T36.7 Antifungal antibiotics, systemically used
0.544 0.456 0.000
T36.6 Rifamycins
0.544 0.456 0.000
T36.5 Aminoglycosides
0.544 0.456 0.000
T36.4 Tetracyclines
0.544 0.456 0.000
T36.3 Macrolides
0.544 0.456 0.000
T36.2 Chloramphenicol group
0.544 0.456 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.544 0.456 0.000
E14 Unspecified diabetes mellitus
0.000 0.457 0.543
K90.9 Intestinal malabsorption, unspecified
0.000 0.469 0.531
E07.9 Disorder of thyroid, unspecified
0.000 0.479 0.521
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.486 0.514
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.486 0.514
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.486 0.514
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.486 0.514
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.486 0.514
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.486 0.514
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.486 0.514
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.486 0.514
E12.9 Without complications
0.000 0.486 0.514
E12.8 With unspecified complications
0.000 0.486 0.514
E12.7 With multiple complications
0.000 0.486 0.514
E12.6 With other specified complications
0.000 0.486 0.514
E12.5 With peripheral circulatory complications
0.000 0.486 0.514
E12.4 With neurological complications
0.000 0.486 0.514
E12.3 With ophthalmic complications
0.000 0.486 0.514
E12.2 With renal complications
0.000 0.486 0.514
E12.1 With ketoacidosis
0.000 0.486 0.514
E12.0 With coma
0.000 0.486 0.514
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.513 0.487 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.513 0.487 0.000
T37.5 Antiviral drugs
0.513 0.487 0.000
T37.4 Anthelminthics
0.513 0.487 0.000
T37.3 Other antiprotozoal drugs
0.513 0.487 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.513 0.487 0.000
T37.1 Antimycobacterial drugs
0.513 0.487 0.000
T37.0 Sulphonamides
0.513 0.487 0.000
T41.5 Therapeutic gases
0.513 0.487 0.000
T41.4 Anaesthetic, unspecified
0.513 0.487 0.000
T41.3 Local anaesthetics
0.513 0.487 0.000
T41.2 Other and unspecified general anaesthetics
0.513 0.487 0.000
T41.1 Intravenous anaesthetics
0.513 0.487 0.000
T41.0 Inhaled anaesthetics
0.513 0.487 0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.513 0.487 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.513 0.487 0.000
T48.5 Anti-common-cold drugs
0.513 0.487 0.000
T48.4 Expectorants
0.513 0.487 0.000
T48.3 Antitussives
0.513 0.487 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.513 0.487 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.513 0.487 0.000
T48.0 Oxytocic drugs
0.513 0.487 0.000
T49.9 Topical agent, unspecified
0.513 0.487 0.000
T49.8 Other topical agents
0.513 0.487 0.000
T49.7 Dental drugs, topically applied
0.513 0.487 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.513 0.487 0.000
T49.5 Ophthalmological drugs and preparations
0.513 0.487 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.513 0.487 0.000
T49.3 Emollients, demulcents and protectants
0.513 0.487 0.000
T49.2 Local astringents and local detergents
0.513 0.487 0.000
T49.1 Antipruritics
0.513 0.487 0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.513 0.487 0.000
E61.1 Iron deficiency
0.000 0.489 0.511
E61.9 Deficiency of nutrient element, unspecified
0.000 0.493 0.507
E61.8 Deficiency of other specified nutrient elements
0.000 0.493 0.507
E61.7 Deficiency of multiple nutrient elements
0.000 0.493 0.507
E61.6 Vanadium deficiency
0.000 0.493 0.507
E61.5 Molybdenum deficiency
0.000 0.493 0.507
E61.4 Chromium deficiency
0.000 0.493 0.507
E61.3 Manganese deficiency
0.000 0.493 0.507
E61.0 Copper deficiency
0.000 0.493 0.507
E50.9 Vitamin A deficiency, unspecified
0.000 0.494 0.506
E50.8 Other manifestations of vitamin A deficiency
0.000 0.494 0.506
E50.7 Other ocular manifestations of vitamin A deficiency
0.000 0.494 0.506
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.000 0.494 0.506
E50.5 Vitamin A deficiency with night blindness
0.000 0.494 0.506
E50.4 Vitamin A deficiency with keratomalacia
0.000 0.494 0.506
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.000 0.494 0.506
E50.2 Vitamin A deficiency with corneal xerosis
0.000 0.494 0.506
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.000 0.494 0.506
E50.0 Vitamin A deficiency with conjunctival xerosis
0.000 0.494 0.506
E51.9 Thiamine deficiency, unspecified
0.000 0.494 0.506
E51.8 Other manifestations of thiamine deficiency
0.000 0.494 0.506
E51.2 Wernicke's encephalopathy
0.000 0.494 0.506
E51.1 Beriberi
0.000 0.494 0.506
E56.9 Vitamin deficiency, unspecified
0.000 0.494 0.506
E56.8 Deficiency of other vitamins
0.000 0.494 0.506
E56.1 Deficiency of vitamin K
0.000 0.494 0.506
E56.0 Deficiency of vitamin E
0.000 0.494 0.506
E63.9 Nutritional deficiency, unspecified
0.000 0.494 0.506
E63.8 Other specified nutritional deficiencies
0.000 0.494 0.506
E63.1 Imbalance of constituents of food intake
0.000 0.494 0.506
E63.0 Essential fatty acid [EFA] deficiency
0.000 0.494 0.506
E64.9 Sequelae of unspecified nutritional deficiency
0.000 0.494 0.506
E64.8 Sequelae of other nutritional deficiencies
0.000 0.494 0.506
E64.3 Sequelae of rickets
0.000 0.494 0.506
E64.2 Sequelae of vitamin C deficiency
0.000 0.494 0.506
E64.1 Sequelae of vitamin A deficiency
0.000 0.494 0.506
E64.0 Sequelae of protein-energy malnutrition
0.000 0.494 0.506
E61.2 Magnesium deficiency
0.000 0.495 0.505
E13.8 With unspecified complications
0.000 0.510 0.489
E13.7 With multiple complications
0.000 0.510 0.489
E13.6 With other specified complications
0.000 0.510 0.489
E13.5 With peripheral circulatory complications
0.000 0.510 0.489
E13.4 With neurological complications
0.000 0.510 0.489
E13.3 With ophthalmic complications
0.000 0.510 0.489
E13.2 With renal complications
0.000 0.510 0.489
E13.1 With ketoacidosis
0.000 0.510 0.489
E13.0 With coma
0.000 0.510 0.489
E04.0 Non-toxic diffuse goitre
0.000 0.511 0.489
E65-E68 Obesity and other hyperalimentation
0.000 0.526 0.474
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.468 0.532 0.000
E14.3 With ophthalmic complications
0.000 0.538 0.462
E07.1 Dyshormogenetic goitre
0.000 0.538 0.461
E07.0 Hypersecretion of calcitonin
0.000 0.538 0.461
E13.9 Without complications
0.000 0.545 0.455
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.555 0.445
T45.9 Primarily systemic and haematological agent, unspecified
0.441 0.559 0.000
T45.8 Other primarily systemic and haematological agents
0.441 0.559 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.441 0.559 0.000
T45.6 Fibrinolysis-affecting drugs
0.441 0.559 0.000
T45.4 Iron and its compounds
0.441 0.559 0.000
T45.3 Enzymes, not elsewhere classified
0.441 0.559 0.000
T45.0 Antiallergic and antiemetic drugs
0.432 0.568 0.000
K90.3 Pancreatic steatorrhoea
0.000 0.568 0.432
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.568 0.432
K90.1 Tropical sprue
0.000 0.568 0.432
T45.5 Anticoagulants
0.420 0.579 0.000
T45.2 Vitamins, not elsewhere classified
0.418 0.582 0.000
T45.1 Antineoplastic and immunosuppressive drugs
0.410 0.589 0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.409 0.591 0.000
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.606 0.394
E45 Retarded development following protein-energy malnutrition
0.000 0.606 0.394
E43 Unspecified severe protein-energy malnutrition
0.000 0.606 0.394
E42 Marasmic kwashiorkor
0.000 0.606 0.394
E41 Nutritional marasmus
0.000 0.606 0.394
E40 Kwashiorkor
0.000 0.606 0.394
E14.1 With ketoacidosis
0.000 0.610 0.390
E14.8 With unspecified complications
0.000 0.611 0.389
E14.7 With multiple complications
0.000 0.611 0.389
E14.6 With other specified complications
0.000 0.611 0.389
E14.2 Withrenal complications
0.000 0.611 0.389
E14.0 With coma
0.000 0.611 0.389
E20-E35 Disorders of other endocrine glands
0.000 0.612 0.388
K90.8 Other intestinal malabsorption
0.000 0.627 0.372
M06.9 Rheumatoid arthritis, unspecified
0.000 0.640 0.360
E14.5 With peripheral circulatory complications
0.000 0.640 0.359
E27 Other disorders of adrenal gland
0.000 0.654 0.346
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)
0.000 0.656 0.344
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)
0.000 0.659 0.341
E67 Other hyperalimentation
0.000 0.660 0.340
E68 Sequelae of hyperalimentation
0.000 0.660 0.340
M06.94 Rheumatoid arthritis, unspecified (Hand)
0.000 0.663 0.337
E14.4 With neurological complications
0.000 0.663 0.337
E11 Non-insulin-dependent diabetes mellitus
0.000 0.667 0.333
E27.1 Primary adrenocortical insufficiency
0.000 0.677 0.323
E70-E90 Metabolic disorders
0.000 0.681 0.319
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.316 0.684 0.000
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)
0.000 0.686 0.314
M06.96 Rheumatoid arthritis, unspecified (Lower leg)
0.000 0.687 0.313
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified
0.000 0.690 0.310
E89.0 Postprocedural hypothyroidism
0.000 0.694 0.306
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)
0.000 0.700 0.300
E11.3 With ophthalmic complications
0.000 0.708 0.292
E22 Hyperfunction of pituitary gland
0.000 0.709 0.291
E44.1 Mild protein-energy malnutrition
0.000 0.717 0.282
E44.0 Moderate protein-energy malnutrition
0.000 0.717 0.282
E04.1 Non-toxic single thyroid nodule
0.000 0.718 0.282
E34 Other endocrine disorders
0.000 0.721 0.278
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.722 0.278
E32 Diseases of thymus
0.000 0.722 0.278
E31 Polyglandular dysfunction
0.000 0.722 0.278
E30 Disorders of puberty, not elsewhere classified
0.000 0.722 0.278
E25 Adrenogenital disorders
0.000 0.722 0.278
M06 Other rheumatoid arthritis
0.000 0.722 0.277
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)
0.000 0.723 0.277
E27.8 Other specified disorders of adrenal gland
0.000 0.723 0.277
E24 Cushing's syndrome
0.000 0.724 0.276
Chapter XIX Injury, poisoning and certain other consequences of external causes
0.274 0.726 0.000
S30-S39 Injuries to the abdomen, lower back, lumbar spine and pelvis
0.271 0.729 0.000
T20-T25 Burns and corrosions of external body surface, specified by site
0.270 0.730 0.000
E11.0 With coma
0.000 0.731 0.268
M06.92 Rheumatoid arthritis, unspecified (Upper arm)
0.000 0.732 0.268
E29 Testicular dysfunction
0.000 0.733 0.267
E11.8 With unspecified complications
0.000 0.733 0.267
E07.8 Other specified disorders of thyroid
0.001 0.735 0.264
E65 Localised adiposity
0.000 0.735 0.264
E73 Lactose intolerance
0.000 0.740 0.260
E85 Amyloidosis
0.000 0.742 0.258
S30 Superficial injury of abdomen, lower back and pelvis
0.254 0.746 0.000
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source
0.251 0.749 0.000
M06.0 Seronegative rheumatoid arthritis
0.000 0.750 0.249
S32 Fracture of lumbar spine and pelvis
0.249 0.751 0.000
E26 Hyperaldosteronism
0.000 0.751 0.249
E27.5 Adrenomedullary hyperfunction
0.000 0.752 0.248
E27.3 Drug-induced adrenocortical insufficiency
0.000 0.752 0.248
E27.0 Other adrenocortical overactivity
0.000 0.752 0.248
L40-L45 Papulosquamous disorders
0.246 0.752 0.002
M07.30 Other psoriatic arthropathies (Multiple sites)
0.247 0.753 0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.000 0.753 0.246
E27.4 Other and unspecified adrenocortical insufficiency
0.000 0.754 0.246
E67.8 Other specified hyperalimentation
0.000 0.756 0.244
E67.3 Hypervitaminosis D
0.000 0.756 0.244
E67.2 Megavitamin-B6 syndrome
0.000 0.756 0.244
E67.1 Hypercarotenaemia
0.000 0.756 0.244
E67.0 Hypervitaminosis A
0.000 0.756 0.244
T22 Burn and corrosion of shoulder and upper limb, except wrist and hand
0.243 0.757 0.000
E27.2 Addisonian crisis
0.000 0.759 0.241
E20 Hypoparathyroidism
0.000 0.759 0.240
T51 Toxic effect of alcohol
0.240 0.760 0.000
M07.3 Other psoriatic arthropathies
0.238 0.761 0.002
E11.7 With multiple complications
0.000 0.761 0.239
S30.2 Contusion of external genital organs
0.239 0.761 0.000
T25 Burn and corrosion of ankle and foot
0.239 0.761 0.000
E89.2 Postprocedural hypoparathyroidism
0.000 0.762 0.238
S10-S19 Injuries to the neck
0.235 0.765 0.000
E74 Other disorders of carbohydrate metabolism
0.000 0.765 0.235
E22.1 Hyperprolactinaemia
0.000 0.765 0.234
E66 Obesity
0.000 0.768 0.232
T21 Burn and corrosion of trunk
0.232 0.768 0.000
M07.39 Other psoriatic arthropathies (Site unspecified)
0.232 0.768 0.000
E84 Cystic fibrosis
0.000 0.771 0.229
E79 Disorders of purine and pyrimidine metabolism
0.000 0.771 0.229
E77 Disorders of glycoprotein metabolism
0.000 0.771 0.229
E76 Disorders of glycosaminoglycan metabolism
0.000 0.771 0.229
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.000 0.771 0.229
E72 Other disorders of amino-acid metabolism
0.000 0.771 0.229
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.000 0.771 0.229
E70 Disorders of aromatic amino-acid metabolism
0.000 0.771 0.229
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.000 0.771 0.229
E89.6 Postprocedural adrenocortical(-medullary) hypofunction
0.000 0.771 0.229
M06.93 Rheumatoid arthritis, unspecified (Forearm)
0.000 0.771 0.228
S32.4 Fracture of acetabulum
0.228 0.772 0.000
E28 Ovarian dysfunction
0.000 0.773 0.227
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.226 0.773 0.000
T40.8 Lysergide [LSD]
0.226 0.773 0.000
T40.7 Cannabis (derivatives)
0.226 0.773 0.000
T40.5 Cocaine
0.226 0.773 0.000
T40.3 Methadone
0.226 0.773 0.000
T40.1 Heroin
0.226 0.773 0.000
T40.0 Opium
0.226 0.773 0.000
E46 Unspecified protein-energy malnutrition
0.001 0.773 0.226
S31 Open wound of abdomen, lower back and pelvis
0.226 0.774 0.000
M06.4 Inflammatory polyarthropathy
0.000 0.774 0.225
T08-T14 Injuries to unspecified part of trunk, limb or body region
0.224 0.776 0.000
E89.9 Postprocedural endocrine and metabolic disorder, unspecified
0.000 0.778 0.222
E89.8 Other postprocedural endocrine and metabolic disorders
0.000 0.778 0.222
E89.5 Postprocedural testicular hypofunction
0.000 0.778 0.222
E89.4 Postprocedural ovarian failure
0.000 0.778 0.222
E89.1 Postprocedural hypoinsulinaemia
0.000 0.778 0.222
T51.0 Ethanol
0.222 0.778 0.000
M06.98 Rheumatoid arthritis, unspecified (Other)
0.000 0.779 0.220
E11.9 Without complications
0.000 0.780 0.220
T22.2 Burn of second degree of shoulder and upper limb, except wrist and hand
0.220 0.780 0.000
S36 Injury of intra-abdominal organs
0.219 0.780 0.000
E73.9 Lactose intolerance, unspecified
0.000 0.782 0.218
E85.9 Amyloidosis, unspecified
0.000 0.783 0.217
S32.5 Fracture of pubis
0.217 0.783 0.000
E34.0 Carcinoid syndrome
0.000 0.784 0.216
M06.09 Seronegative rheumatoid arthritis (Site unspecified)
0.000 0.785 0.215
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.785 0.215
S32.40 Fracture of acetabulum (closed)
0.213 0.787 0.000
M06.00 Seronegative rheumatoid arthritis (Multiple sites)
0.000 0.788 0.212
E83 Disorders of mineral metabolism
0.000 0.788 0.212
T23 Burn and corrosion of wrist and hand
0.211 0.789 0.000
E11.1 With ketoacidosis
0.000 0.789 0.211
T51.9 Alcohol, unspecified
0.211 0.789 0.000
T20 Burn and corrosion of head and neck
0.210 0.790 0.000
E22.9 Hyperfunction of pituitary gland, unspecified
0.000 0.791 0.208
E22.8 Other hyperfunction of pituitary gland
0.000 0.791 0.208
S30.1 Contusion of abdominal wall
0.208 0.792 0.000
T25.0 Burn of unspecified degree of ankle and foot
0.207 0.793 0.000
E11.5 With peripheral circulatory complications
0.000 0.793 0.206
E83.1 Disorders of iron metabolism
0.000 0.795 0.205
T00-T07 Injuries involving multiple body regions
0.205 0.795 0.000
T29-T32 Burns and corrosions of multiple and unspecified body regions
0.204 0.795 0.000
E34.5 Androgen resistance syndrome
0.000 0.800 0.200
E34.4 Constitutional tall stature
0.000 0.800 0.200
E34.3 Short stature, not elsewhere classified
0.000 0.800 0.200
E34.2 Ectopic hormone secretion, not elsewhere classified
0.000 0.800 0.200
E34.1 Other hypersecretion of intestinal hormones
0.000 0.800 0.200
E25.9 Adrenogenital disorder, unspecified
0.000 0.800 0.200
E25.8 Other adrenogenital disorders
0.000 0.800 0.200
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.000 0.800 0.200
E30.9 Disorder of puberty, unspecified
0.000 0.800 0.200
E30.8 Other disorders of puberty
0.000 0.800 0.200
E30.1 Precocious puberty
0.000 0.800 0.200
E30.0 Delayed puberty
0.000 0.800 0.200
E31.9 Polyglandular dysfunction, unspecified
0.000 0.800 0.200
E31.8 Other polyglandular dysfunction
0.000 0.800 0.200
E31.1 Polyglandular hyperfunction
0.000 0.800 0.200
E31.0 Autoimmune polyglandular failure
0.000 0.800 0.200
E32.9 Disease of thymus, unspecified
0.000 0.800 0.200
E32.8 Other diseases of thymus
0.000 0.800 0.200
E32.1 Abscess of thymus
0.000 0.800 0.200
E32.0 Persistent hyperplasia of thymus
0.000 0.800 0.200
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.000 0.800 0.200
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.000 0.800 0.200
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.000 0.800 0.200
S10 Superficial injury of neck
0.200 0.800 0.000
M06.8 Other specified rheumatoid arthritis
0.000 0.801 0.199
M06.2 Rheumatoid bursitis
0.000 0.801 0.199
M06.1 Adult-onset Still's disease
0.000 0.801 0.199
T40.6 Other and unspecified narcotics
0.198 0.801 0.000
E34.9 Endocrine disorder, unspecified
0.000 0.802 0.198
E24.9 Cushing's syndrome, unspecified
0.000 0.802 0.198
S80-S89 Injuries to the knee and lower leg
0.198 0.802 0.000
E24.8 Other Cushing's syndrome
0.000 0.802 0.198
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.000 0.802 0.198
E24.3 Ectopic ACTH syndrome
0.000 0.802 0.198
E24.1 Nelson's syndrome
0.000 0.802 0.198
E24.0 Pituitary-dependent Cushing's disease
0.000 0.802 0.198
S30.8 Other superficial injuries of abdomen, lower back and pelvis
0.197 0.803 0.000
T33-T35 Frostbite
0.196 0.804 0.000
T26-T28 Burns and corrosions confined to eye and internal organs
0.196 0.804 0.000
E24.2 Drug-induced Cushing's syndrome
0.000 0.805 0.195
S38 Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis
0.195 0.805 0.000
S35 Injury of blood vessels at abdomen, lower back and pelvis level
0.195 0.805 0.000
S34 Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level
0.195 0.805 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.